Friday, October 4, 2024

Canada’s Politics and Government News Source Since 1989

Friday, October 4, 2024 | Latest Paper

TRENDING:

Innovation is the talk of the town

Our decision-makers must seize the opportunity, optimize our first-mover advantage and our national interests, and support Canada’s leadership. Stable, long-term funding for stem cell research and regenerative medicine should be our number-one proof point of Canada’s commitment to science.

Opinion
BY MICHAEL A. RUDNICKI
February 6, 2018

Opinion | BY MICHAEL A. RUDNICKI | February 6, 2018

See all stories BY MICHAEL A. RUDNICKI

More Opinion

Canada needs a modern, national health data architecture

OpinionBY WILL FALK, TREVOR JAMIESON

To address online harms, Canada must commit to digital media literacy

OpinionBY KARA BRISSON-BOIVIN

Renewable energy is the way to go, says letter writer

Supporting local broadcasters is critical for our democracy

OpinionBY ALEX FREEDMAN

Canada playing catch up with its Sudan response

OpinionBY SCOTT TAYLOR

Related Stories

How Canada can take the lead in biomedical engineering

OpinionBY PETER ZANDSTRA

Time to go on offence with Canada’s bio-manufacturing strategy

OpinionBY MICHAEL MAY

Celebrating Canada’s top natural sciences, engineering researchers

OpinionBY ALEJANDRO ADEM

Without new funding, key part of Canada’s stem cell research ecosystem to close

OpinionBY CINDI MORSHEAD, SOWMYA VISWANATHAN

Advancements in biotech and life sciences provide robust benefits for Canada

OpinionBY NAVDEEP BAINS